O
Ol vier Trédan
Publications - 1
Citations - 822
Ol vier Trédan is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications receiving 685 citations.
Papers
More filters
Journal ArticleDOI
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau,Christophe Le Tourneau,Jean Pierre Delord,Anthony Gonçalves,Céline Gavoille,Coraline Dubot,Nicolas Isambert,Mario Campone,Ol vier Trédan,Marie Ange Massiani,Cecile Mauborgne,Sebastien Armanet,Nicolas Servant,Ivan Bièche,Virginie Bernard,David Gentien,Pascal Jézéquel,Valéry Attignon,Sandrine Boyault,Anne Vincent-Salomon,Vincent Servois,Marie Paule Sablin,Maud Kamal,Xavier Paoletti,Xavier Paoletti +24 more
TL;DR: The efficacy of several molecularly targeted agents marketed in France, which were chosen on the basis of tumour molecular profiling but used outside their indications, in patients with advanced cancer for whom standard-of-care therapy had failed is assessed.